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Recombinant proteins are primarily produced from cultures of mammalian, insect, and bacteria cells. In recent years, the
development of deconstructed virus-based vectors has allowed plants to become a viable platform for recombinant protein
production, with advantages in versatility, speed, cost, scalability, and safety over the current production paradigms. In this paper,
we review the recent progress in the methodology of agroinfiltration, a solution to overcome the challenge of transgene delivery
into plant cells for large-scale manufacturing of recombinant proteins. General gene delivery methodologies in plants are first
summarized, followed by extensive discussion on the application and scalability of each agroinfiltrationmethod. New development
of a spray-based agroinfiltration and its application on field-grown plants is highlighted. The discussion of agroinfiltration vectors
focuses on their applications for producing complex and heteromultimeric proteins and is updated with the development of
bridge vectors. Progress on agroinfiltration in Nicotiana and non-Nicotiana plant hosts is subsequently showcased in context
of their applications for producing high-value human biologics and low-cost and high-volume industrial enzymes. These new
advancements in agroinfiltration greatly enhance the robustness and scalability of transgene delivery in plants, facilitating the
adoption of plant transient expression systems for manufacturing recombinant proteins with a broad range of applications.
1. Introduction
The approval of the first plant-derived therapeutic enzyme
for Gaucher’s disease has demonstrated the promise of plant-
based systems for recombinant protein (RP) production [1].
In addition to the traditional advantages in cost, scalability,
and safety over current bioreactor-based production platfo-
rms, progress in glycoengineering and expression vector dis-
covery has also allowed plants to produce RPs with specific
glycoforms to enhance functionality and at unprecedented
speed to control potential pandemics and fight bioterrorism
[2].
The traditional strategy of producing RPs in plants is to
create stable, transgenic lines of plants.The target transgene is
integrated into the plant genome and the RP can be produced
in successive generations [3]. To eliminate the long time
frame of generating transgenic plants, transient expression
systems have been developed. In this strategy, the transgene is
not integrated into the plant genome but rather quickly
directs the production of the RP while residing transiently
within the plant cell. In addition to significantly shortening
the production timeline, this strategy also enhances RP accu-
mulation level by eliminating the “position effect” of variable
expression caused by the random integration of transgene
within the genome [4]. Besides its speed and high yield,
the transient expression system also offers the versatility for
producing personalized RPs, such as therapeutics for patient-
specific cancers and vaccines against viruses that have rapid
antigenic drift and/or multiple strains with unpredictable
outbreaks. This flexibility also provides the “surge” capa-
bility to rapidly produce recombinant counteragents in a
bioterrorism event. Since no transgenic plant is created, tran-
sient expression also addresses regulatory issues and public
concerns for genetically modified organisms (GMOs). These
advantages demonstrate the vast potential of transient expres-
sion as a preferred method for RP production in plants.
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However, scale-up of RP production by transient expression
poses a bigger challenge than transgenic plants, because no
genetically stable seed bank is produced and scale-up is no
longer just a matter of increasing acreage to boost yield. To
overcome this challenge, a scalable transgene delivery meth-
od must be developed for plant transient expression.
2. Methods of Transgene Delivery
The method of choice for introducing transgenes into plants
depends on the expression vector and the host plants. These
methods include direct delivery by gene gun and indirect
delivery through using Agrobacterium tumefaciens or plant
viruses [5].
2.1. Direct Delivery Methods. DNA or RNA can be directly
introduced into plant cells via a so-called microprojectile
bombardmentmethod, also known as a gene gun or biolistics.
In this method, the transgene is coated onto microgold or
tungsten particles and fired into plant cells ballistically [6].
The advantage of this method resides in its versatility and a
broad range of susceptible plants. It can be used to deliver
transgene to both nuclear and chloroplast genomes. At least
in theory, effective transgene delivery by biolistics is vector
independent and can be applied to any plant host species [5].
2.2. Indirect GeneDeliveryMethods. Indirect transgene deliv-
ery exploits the ability of plant virus or certain pathogenic
agrobacteria species (e.g., A. tumefaciens) that naturally
transfer their genome (plant virus) or part of their tumor
inducing plasmid (Ti plasmid) DNA (T-DNA) into plant cells
(Agrobacterium). A transgene can enter plant cells as a by-
product of viral infection if cloned into the full viral genome.
Infection can be facilitated by rubbing plant tissue with a
transgene carrying infectious viral particles or viral nucleic
acids [3]. However, this method is only applicable to viruses
or plant hosts that are susceptible to mechanical inoculation
but not to those that require specialized insects for viral trans-
mission.
Ti plasmids of Agrobacterium can be modified into deliv-
ery vectors by replacing pathogenic genes in T-DNA with
transgenes; transgene transfer from agrobacteria to plant cells
is accomplished through the natural interaction between A.
tumefaciens and its plant hosts [5]. In contrast to biolistics,
gene delivery by A. tumefaciens requires the cloning of trans-
gene into a modified Ti plasmid and is restricted to dicotyle-
donous and a limited number of monocotyledonous plants
[7]. However, delivery by Agrobacterium generally offers
better efficiency, transgene expression, and inheritance than
biolistics [5]. It is speculated that Agrobacterium-based deliv-
ery is advantageous because transgene copy numbers and
integration into the genome are better controlled.The coevo-
lution ofAgrobacterium and its plant hostsmay favor the inte-
gration of transgenes into genomic loci that are transcrip-
tionally active, which leads to its high level of expression
[7]. In transient expression, biolistics often cause severe
tissue damage and effectively reduce the available biomass for
RP production, making indirect delivery by Agrobacterium
a preferredmethod. As a result, anAgrobacterium-based gene
delivery via agroinfiltration has become the favorable gene
delivery method for transient expression in plants [7, 8].
3. Agroinfiltration for Expression of
Recombinant Proteins
On a per cell basis, the yield of a RP is usually higher in tra-
nsient expression than that in transgenic plants [4]. The
elimination of the “position effect” is responsible for this imp-
rovement as the transgene is no longer randomly inserted
into genomic areas with variable transcriptional activity [9].
However, earlier gene delivery methods consisted of soaking
leaf pieces in Agrobacterium culture in which only the cell
layer on the edges may receive the transgene. This limits the
efficiency and scalability of transient systems.
Agroinfiltration was invented to overcome this challenge.
Because up to one-third of the leaf volume is intercellular
space, it is possible to replace the air in these cavities with
a suspension of Agrobacterium [1]. Thus, transgene-carrying
agrobacteria are actively delivered into the intercellular space
of the leaf tissue by agroinfiltration, allowing for the effective
access of agrobacteria to most leaf cells and making the
transfer of T-DNA a highly efficient event [8, 10].
3.1. Application and Scalability of Agroinfiltration. The sim-
plest method of agroinfiltration is syringe infiltration. In this
method, transgene-carryingAgrobacterium in the infiltration
medium is injected into the leaf with a needleless syringe
(Figure 1(a)). Syringe infiltration offers the flexibility of intro-
ducing multiple transgene constructs into different areas,
allowing multiple assays to be performed on a single leaf [8].
Thus, it has been used for studying plant-pathogen interac-
tions, abiotic stresses, gene functional analysis, protein local-
ization, and protein-protein interactions [8]. Syringe infiltra-
tion also has numerous applications for RP production. For
example, it can be used to quickly examine the expression
level of a RP under established conditions (Figure 1(b)). If
further optimization of expression is necessary, its flexibility
permits a quick assessment of various factors’ effects on the
yield, expression kinetics, and toxicity of the target protein.
These factors include concentrations of Agrobacterium cul-
ture, different expression vectors, organelles favorable for RP
accumulation, and the requirement for silencing suppressors.
Once optimized, syringe infiltration can also be used to infil-
trate several entire plants to rapidly obtain sufficient amounts
(milligram level) of RPs for biochemical characterization and
preclinical functional studies, as well as for developing puri-
fication schemes. Despite these utilities, only a few plant
species are naturally amenable to syringe infiltration and the
prospect of its scalability is highly limited [11].
A scalable agroinfiltration technology will enhance the
competitiveness of transient expression systems with the tra-
ditional cell culture-based platforms for RP production. An
agroinfiltration method using a vacuum chamber was devel-
oped for such purposes [5]. A prototype apparatus routinely
used in the laboratory is best illustrative of the vacuum
chamber method. First, aerial parts of plants are submerged
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Figure 1: Transgene delivery by agroinfiltration intoN. benthamiana and lettuce plants. Agrobacteria carrying the expression cassette of GFP
or DsRed in geminiviral vectors were syringe-infiltrated into a N. benthamiana leaf (a) and GFP or DsRed expression was observed 4 days
after infiltration under UV light (b). Similarly, A. tumefaciens cells harboring the expression cassette of GFP in a geminiviral vector were
vacuum infiltrated into a lettuce plant (c) and GFP expression was examined 4 days after infiltration (d). The yellow spot in (b) indicates the
leaf area that was coinfiltrated with agrobacteria carrying the expression cassette of GFP and DsRed.
into an Agrobacterium suspension.The submerged plants are
then transferred into a desiccator that serves as the vacuum
chamber. A pump provides the vacuum that exposes the sub-
merged plants to a negative atmospheric pressure and draws
the air out of the interstitial space of the leaves. Agroinfil-
tration is achieved when the vacuum is released, allowing
agrobacteria in the medium to enter the intercellular space
once occupied by the air (Figure 1(c)).
Vacuum infiltration can efficiently infiltrate plant species
that are unamenable to syringe infiltration, effectively expan-
ding the host range of agroinfiltration [12–14]. Furthermore,
studies demonstrated that vacuum infiltration resulted in
similar yield and temporal expression patterns for several RPs
compared to that of syringe infiltration.This suggests that the
results from the two agroinfiltration methods are mutually
transferable; the simple syringe infiltration can accurately
predict the expression pattern of aRP in scale-up settings.Not
surprisingly, research has shown the superiority of vacuum
infiltration in speed and robustness over syringe infiltration.
For example, as the entire plant is subjected to agroinfiltration
with vacuum, the expression of the RP can be detected in
all leaves of the entire plant (Figure 1(d)). Even at bench
scale, the time required for infiltrating a single 6-week-old
N. benthamiana plant is significantly shortened 30 times by
vacuum infiltration [15].
The scalability of vacuum infiltration has been examined
for the production of RPs with biomedical applications.
To test its scalability beyond the desiccator prototype, we
designed a vacuum chamber that is able to accommodate 16
trays of plants per infiltration cycle. Results indicated that
vacuum infiltration is highly scalable. Specifically, the accu-
mulation level and the temporal expression patterns of virus-
like particles (VLPs) of norovirus andmonoclonal antibodies
(MAbs) against West Nile virus (WNV) were not affected,
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Figure 2: N. benthamiana plant growth (a) and agroinfiltration (b) at commercial production scale at Kentucky Bioprocessing LLC.
regardless of whether they were produced under scale-up
conditions or with the desiccator [16–19]. This pilot-scale
system has enabled us to produce the norovirus vaccine can-
didate under current good manufacturing practice (cGMP)
regulations which is sufficient both in quality and quantity
for a phase I human clinical trial [16, 20, 21]. Biotechnol-
ogy companies have further explored the scalability of this
method. For example, a fully automated vacuum system was
developed with the capability to agroinfiltrate up to 1.2 tons
of plant biomass per day, allowing for the production of up to
75 g ofMAb-based therapeutics per greenhouse lot (Figure 2)
[1, 15, 22]. This process can be further scaled up, but its
requirement of inverting plants grown in pots or trays may
impose limitations on the ways the plants can be cultivated
and may confine the use of vacuum infiltration to high-value
RPs, such as vaccines and therapeutics.
For even larger scale RP production, especially for low-
cost but high-volume RPs, it is desirable to develop new agro-
infiltration technologies that allow gene delivery to whole
plants without using a vacuum. Fortunately, as only nontrans-
genic plant material is used in transient expression, biomass
can be generated in open fields by conventional agricultural
practices without concerns for GMO. This allows the explo-
ration of a spray-based agroinfiltration method to deliver
transgene into field-grown plants. Initially, approximately 2%
of leaf cells can receive and express the transgene through
spray agroinfiltration [1]. New developments in this method-
ology include the use of surfactant and/or abrasives in
the Agrobacterium suspension to enhance transfection and
new Agrobacterium strains with super transfectivity [1, 23].
When improved spray agroinfiltration is combined with an
expression vector that can generate a replicon with cell-to-
cell movement capability, up to 90% of leaf cells can receive
the transgene and express the target protein at high levels of
50% total soluble protein (TSP) [1]. This provides a simple
and indefinitely scalable process of transgene delivery into
field-grown plants, allowing transient expression on a large
agricultural scale.The demonstration of large-scale agroinfil-
tration under the US Food and Drug Administration’s (FDA)
cGMP guidelines supports the regulatory compliance of this
technology and extends its application to manufacture RPs
with human biomedical interests. Collectively, these studies
demonstrate that the value of vacuum and spray agroinfiltra-
tion lies in their enormous scalability potential, facilitating
the adoption of plant transient expression-based systems for
commercial manufacturing of RPs.
3.2. Vectors for Agroinfiltration. Agroinfiltration is versatile
and can be performed with any vectors as long as they can
replicate in A. tumefaciens and initiate T-DNA transfer with
the help of virulent genes on chromosomes and/or another
plasmid [8].The earliest vectors used for agroinfiltrationwere
transcriptional vectors such as pBIN19 or pCAMBIA, driven
by nopaline synthase (pnos) or cauliflower mosaic virus
(CaMV) 35S promoters (CaMV35S). While these transcrip-
tional vectors are not as robust as later developed plant virus-
based vectors, they do have a broad host range and can be
used in almost all plant species. It is these vectors that demon-
strated the superiority of transient expression in regard to the
speed and RP yield over the traditional protein expression in
transgenic plants [20, 24, 25].
The robust replication and/or transcription of plant
viruses has led to the development of viral vectors for enhanc-
ing the RP yield [25]. Each type of plant virus offers its unique
advantages and limitations as an agroinfiltration vector and
may be useful for the production of a specific type of RP.
For example, double-stranded DNA plant viruses such as
CaMV are useful only for producing small RPs, because they
have limited packaging capacity and can lose their genome
functions when a fraction of their genomes are removed or
substituted [25]. In contrast, single-stranded RNA viruses
(e.g., tomato busy stunt virus (TBSV), tobacco mosaic virus
(TMV), and potato virus X (PVX)) offer vectors for express-
ing large RPs, because they are more tolerant to large gene
substitutions and insertions [25]. However, these RNA-based
vectors have to be generated by an unscalable in vitro process.
“Deconstructed” viral vectors represent a new generation
of vectors that combine the robustness of full viral vectors and
the versatility of nonviral vectors. The elimination of unnec-
essary or unbeneficial genomic components during viral dec-
onstruction significantly reduces the size of the replicon,
allowing the insertion of larger transgenes while maintaining
the robustness of viral replication and transcription. Decon-
structed RNA viral vectors can be delivered in the form of
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DNA which will be transcribed and spliced into autonomous
replicons in plant cells [25]. This not only effectively elim-
inates the need for generating RNA vectors by an in vitro
process but also allows for all deconstructed viral vectors
to be delivered by agroinfiltration. Since agroinfiltration can
deliver vectors to most of the cells on the entire plant
[15], the viral systemic spreading function is no longer
needed. This alleviates the concern for transgene loss during
systemic spreading and allows the deletion of coat protein
to accommodate larger transgene insertion. Agroinfiltration
also broadens the range of plant species susceptible to viral
vector delivery beyond the natural virus hosts and allows for
the delivery of vectors that are notmechanically transmissible
in nature.Therefore, the development and application of dec-
onstructed viral vectors not only overcome the limitations
of full viral vectors but further enhance their versatility and
transgene expression in transient systems.
The most commonly used deconstructed vectors rely on
theMagnICON system, derived from TMV [26].This system
can be used either in themodular or the fully assembled form,
depending on the application.Themodular system facilitates
simple cloning of the transgene because it is located in a sepa-
rated plasmid of reasonable size. Furthermore, the transgene
in the 3󸀠 module can be paired with a suite of 5󸀠 modules
that contains different promoters and/or targeting sequences
to various organelles. As a result, the modular MagnICON
system provides the flexibility to test the expression of a
transgenewith different promoters and in different organelles
by simply mixing different A. tumefaciens strains that carry
various modules. Thus, it is best suited for the optimization
of transgene expression and small scale RP production. In
contrast, the fully assembled system sacrifices the flexibility
to gain robustness for industrial scale production. It requires
only one vector and one A. tumefaciens culture for agroin-
filtration, greatly simplifying the upstream processing and
reducing the overall cost of good.TheMagnICON system has
been tested at various production scales, from a few plants
in a laboratory to 1.2 tons of plant material/day in industry.
Collectively, they demonstrated that very high level accumu-
lation of RPs (up to 5mg per g leaf freshweight (LFW)) can be
achievedwithin 7–10 days after infiltration (dpi).They include
RPs of all sizes and complexity, ranging from small subunit
vaccines to large tetravalent antibodies [16, 17, 26–29].
In spite of the success, the current MagnICON system
cannot produce RPs withmore than two heterosubunits.This
problem is associated with the phenomenon called “compet-
ing replicons,” as codelivery of viral vectors built on the
same viral backbone often results in early segregation
and subsequent preferential amplification of only one of the
vectors in a single cell [25]. For example, TMV and PVX are
both competing viruses, but not with each other. If the heavy
(HC) and light chain (LC) genes of a MAb are both cloned
into the TMV or PVX vector, only one of the chains will be
produced in a single cell and assembled MAb will not be
produced. However, if the HC and LC gene are built on the
TMV and PVX backbone, respectively, both chains can be
expressed in the same cell, permitting their proper assembly
into a functional MAb. [26]. This allows the MagnICON
system to produce MAbs. However, identifying additional
Rep
LB RB
LIR LIRSIRGOI
Figure 3: Geminiviral BeYDV vector for expression of recombinant
proteins. The left (LB, pink triangle) and right border (RB, pink
triangle) delineate the T-DNA construct that will be transferred
into plant cells by Agrobacterium. Upon delivery into plant cells,
expression of Rep gene produces the Rep protein (brown cloud)
that nicks the LIRs (red stars) in the T-DNA to release a single-
stranded DNA molecule (between the two yellow arrows). This
DNAmolecule recircularizes and is copied tomake double-stranded
DNAs that can replicate by the rolling circle mechanism to produce
very high copy numbers of DNA templates (circles) and, in turn,
abundant mRNAs of gene of interest (GOI) for the translation of the
recombinant protein. Blue star: SIR; pink triangle: LB and RB of the
T-DNA; red stars: LIRs; green arrow: gene of interest; brown cloud:
Rep protein.
viruses that are noncompeting with both TMV and PVX
for expressing proteins with three or more distinct subunits
is a very difficult if not impossible task [20, 30]. We have
circumvented this problem by developing a noncompeting
vector system based on bean yellow dwarf virus (BeYDV),
a monopartite virus in the Geminiviridae family [31]. Upon
infection of plant cells, very high copy numbers of BeYDV
genome are produced by rolling circle replication, which
requires only one single viral protein (replication associated
proteins (Rep)) (Figure 3) [31]. In the first generation of
geminiviral vectors, the transgene and the Rep protein are
supplied in two separate modules [19, 31]. Coagroinfiltration
of the two modules resulted in high-level accumulation of
RPs, which can be further increased by including a third
module carrying a suppressor of gene silencing from TBSV
(P19) [19]. For example, we showed that inclusion of the third
P19 module increased the accumulation of hepatitis B core
antigen (HBcAg) in N. benthamiana >4-fold [21]. Southern
and Northern blot analyses indicated that codelivery of P19
only marginally increased the replicon copy number but
greatly enhanced the accumulation ofHBcAg-specificmRNA
[21].These results indicate that P19 indeed can increase target
mRNA and protein accumulation, most likely by suppressing
posttranscriptional silencing of the transgene. We then
integrated the transgene, Rep, and P19 modules into a single
vector system and demonstrated that the geminiviral system
is noncompeting and permits the efficient expression and
assembly of MAbs [32]. For large-scale manufacturing, we
developed a single vector system that contains multiple repli-
con cassettes with each encoding for a distinct protein. Upon
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Table 1: Examples of recombinant proteins produced in plants by agroinfiltration.
Plant host Vector Biologic target Development stage References
N. benthamiana Nonviral vector Influenza A H5N1 HA VLP vaccine Phase I/II human trial [38, 39]
N. benthamiana TMV NHL personalized vaccine Phase I human trial [37, 40]
N. benthamiana CPMV BTV 4-component VLP vaccine Preclinical [30]
N. benthamiana (WT, ΔXF) TMV/PVX Tetravalent antibody WNV therapeutic Preclinical [28, 41]
N. benthamiana TMV Cellulases for ethanol production Early development [1, 42]
N. benthamiana TMV/PVX Ebola immune complex-based vaccine Preclinical [27, 43]
N. benthamiana TMV, BeYDV, CPMV HBcAg nonenveloped VLP vaccine Preclinical [19, 44]
Lettuce, N. benthamiana TMV/PVX, BeYDV Ebola therapeutics based on MAb Preclinical [18, 32, 34, 45]
Lettuce, N. benthamiana TMV, BeYDV Norovirus NVCP VLP vaccine Preclinical [19, 34, 46]
Lettuce, N. benthamiana TMV/PVX, BeYDV WNV therapeutics based on MAb Preclinical [17, 28, 34]
Lettuce, N. benthamiana (WT, ΔXF) TMV, BeYDV WNV DIII vaccine Preclinical [31, 34, 47]
HA: hemagglutinin; VLP: virus-like particle; NHL: non-Hodgkin’s lymphoma; BTV: bluetongue virus; WT: wild-type; ΔXF: plants with double knockdown of
𝛽-1,2-xylose and core 𝛼-1,3-fucose; WNV:West Nile virus; HBcAg: hepatitis B core antigen; MAb: monoclonal antibody; NVCP: Norwalk virus capsid protein;
DIII: domain III of envelope protein.
agroinfiltration into plant cells, each cassette was shown to
assemble into an independent replicon and produces high
levels of the protein/subunit it codes for, without competing
with the replication of other replicons or the production of
other proteins [32]. This single vector system obviates the
need to generate several vector modules and manufacture
multiple inocula of A. tumefaciens strains, further reducing
capital and operational cost. Recently, a different geminiviral
vector based on the mild strain of BeYDV-m has been
developed and has shown its robustness in expressing two
vaccine candidates [33]. These geminiviral systems may have
broader plant host ranges than theMagnICON system [18, 19,
32, 34]. Overall, the geminiviral replicon system overcomes
the difficulty of producing multiple heterosubunit proteins.
Other examples of deconstructed viral vectors include
systems based on 5󸀠 and 3󸀠 untranslated regions (UTRs) of
cowpea mosaic virus (CPMV) RNA-2 and tobacco yellow
dwarf Mastrevirus (TYDV) [35, 36]. One version of the
CPMV-based vectors is replication independent and, there-
fore, has great promise for agroinfiltration in plant hosts
that are not compatible with replication-dependent vector
systems. Excitingly, the CPMV-based vector has allowed the
expression and assembly of Bluetongue VLPs inN. benthami-
ana that requires coexpression of four different protein
components [30]. These plant-produced VLPs were shown
to be immunogenic and provide protective immunity in
sheep against a challenge of a Bluetongue virus field isolate,
demonstrating the utility of this vector in producing complex
and heteromultimeric proteins [30].The TYDV-based vector
system represents “bridge” vectors that allow the stable inher-
itance of the transgene and a robust yet controlled transient
expression of a RP upon the induction with a specific chem-
ical signal [36]. Plants are allowed to accumulate biomass
in the growth phase while the integrated transgene remains
silent and replicon amplification will be triggered upon ind-
uction for RP production. This type of bridge vector system
effectively combines the strengths of both the stable and tran-
sient expression systems and potentially offers a complete
platform for the rapid assessment of RP candidates and their
transition to a large-scale commercial production.
3.3. Plant Hosts for Agroinfiltration. A prerequisite for a plant
species to be successfully agroinfiltrated is its susceptibility to
A. tumefaciens infection. Among susceptible plants, however,
the amenability of different species to agroinfiltration varies
significantly due to leaf structural differences in the cuticle,
the density of stomata on the epidermis, and the compactness
of mesophyll cells. Due to technological improvements, a
rapidly expanding spectrum of plant species is now amenable
for transgene delivery by agroinfiltration. Since transient
expression systems for RP production do not generate trans-
genic plants, it does not have the risk of contaminating food
crops or unintended transgene escape. This further expands
plant hosts infected via agroinfiltration as an acceptable tech-
nology to the public and regulatory agencies. The choice of a
particular plant host for protein expression is determined by
its compatibility with available expression vectors, the nature
of the target RP, and the scale of production.
3.3.1. Nicotiana Hosts. Themost popular host plant for agro-
infiltration is N. benthamiana and related Nicotiana plants
including tobacco. Besides being most amenable to agroin-
filtration, these plants can produce large amount of biomass
rapidly and are prolific seed producers for the industrial scale-
up of production [20]. In addition, they are permissive to the
replication of a variety of replicon-based vectors. The FDA
and other regulatory agencies are familiar with clinical trial
materials from these plant hosts, thus facilitating their accep-
tance in regulation-compliant processes [29, 37]. As a result,
numerous RPs of various natures, sizes, and applications have
been produced in Nicotiana hosts (Table 1). The examples
below demonstrate the advantages and versatility of utilizing
these plant hosts for agroinfiltration.
In a clinical trial,Nicotiana host-produced biologics were
used to treat Non-Hodgkin’s lymphoma (NHL). NHL is
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a group of blood cancers that is estimated to result in
over 70,800 new cases in the USA alone in 2014. In NHL,
each malignant B cell clone expresses a unique cell surface
immunoglobulin (Ig) as the tumor-specific marker, making
standard treatments ineffective. The variable nature of NHL
calls for patient-specific cancer treatments that require an
expression system with the flexibility to rapidly produce
patient-specific vaccines. One of these vaccines consists of
MAbs derived from each patient’s own tumor. The cell cul-
ture-based production platforms do not have the speed and
flexibility to produce these personalized vaccines. In con-
trast, plant production systems based on agroinfiltration can
provide the optimal platform to meet this demand. Results
showed that 20 patient-specific MAbs were produced at high
levels inN. benthamiana leaves within twoweeks of agroinfil-
tration [29]. The manufacturing process is robust, requiring
only twoweeks forMAb-based vaccine expression and purifi-
cation and less than 12 weeks from biopsy to vaccination [29].
To test the safety and immunogenicity of the plant-expressed
vaccine candidates, a phase I human clinical trial was initiated
with 12 patients. Results indicated that the vaccine was well-
tolerated without major side effects and 73% of the patients
developed a tumor-specific immune response [37, 40]. This
study demonstrated the rapidness and versatility of the
agroinfiltration-based transient system in generating multi-
ple patient-specific cancer vaccines and showcased the capac-
ity of N. benthamiana in producing vaccines that are safe to
administer and effective in the treatment NHL patients.
Nicotiana plant hosts were also utilized for commercial
scale enzyme production. In the production of ethanol as
a fuel extender, large quantities of cellulase are needed to
saccharify cellulosic feedstocks. For more than 30 years, the
high cost of cellulase from fungal fermentation has been
a major impediment to the economic viability of cellulosic
ethanol programs [48]. To reduce the cost of cellulase, N.
benthamianawas used as a host to produce four cellulases for
cell wall degradation via agroinfiltration [42]. Results showed
that all four cellulases were expressed at high levels, up to
75%TSP [42]. Further analysis indicated that plant-produced
cellulases are functional, efficiently converting cellulose to
glucose [42]. Similar results were obtained between using
syringe and spray agroinfiltration, indicating the scalability
of the upstream process [42]. Importantly, the necessity of
purification and costs associated therewith are avoided in
the downstream processing, as the cellulases can be simply
preserved at room temperature for up to four months in
dehydrated N. benthamiana biomass as silage [42]. Technoe-
conomic analysis of a similar cellulase production system
based on transgenic N. tabacum concludes that the plant-
based system may offer a >30% reduction in unit production
costs and an 85% reduction in the required capital investment
comparedwith the current fungal-based fermentation system
[49].We speculate that the systembased on spray agroinfiltra-
tion may result in a similar cost-saving benefit, presenting a
system of cellulase production with unprecedented efficiency
and cost-effectiveness. This process can find broad applica-
tions for production of other cost-sensitive RPs.
N. benthamiana hosts also offer opportunities to produce
RPs with enhanced functionalities (biobetters). For example,
N. benthamiana with “humanized” glycosylation pathways
have been developed to enhance the safety and efficacy of
plant-producedMAbs [50].The difference inN-glycosylation
between plant and mammalian-produced MAbs may alter
the stability and/or efficacy of plant-producedMAbs or cause
potential adverse effects through immune complex forma-
tion. To overcome this challenge, a double knockdown (ΔXF)
N. benthamiana line was created to suppress the production
of the two plant-specific glycans: 𝛽-1,2-xylose and core 𝛼-1,3-
fucose [51]. Results indicated that anti-EbolaMAbs produced
in theΔXFplant line had no plant-specificN-glycans but con-
tained the highly homogenous (90%) mammalian glycoform
GnGn [52]. The lack of fucose and the high homogeneity of
plant-derived MAbs have led to their higher affinity to the
Fc receptor (FcgRIII) and their enhanced potency against
Ebola virus over the mammalian cell-produced MAbs [52].
The superior potency of plant-produced MAbs was further
demonstrated in a challenge study with nonhuman primates,
in which plant-produced MAbs were far more protective
against a lethal Ebola challenge than those produced inmam-
malian cells [45]. In a remarkable and exciting development,
these plant-made MAbs were recently used to treat two
American Ebola patients and showed promising results [53].
Similarly, our studies showed that ΔXF plant-derived anti-
WNVMAbs displayed enhanced viral neutralization in com-
parison to their mammalian counterparts [28]. These newN.
benthamianahosts are being applied to produce biobetter RPs
beyond the realm of MAbs.
3.3.2. Non-Nicotiana Hosts. Certain RPs require a non-Nico-
tiana plant host for their optimal expression. Fortunately,
improvements in technologies have allowed the application
of agroinfiltration to many plant species beyond Nicotiana
plants, including lettuce, tomato, alfalfa, petunia, potato,
cotton, grapevine, switchgrass, radish, pea, lupine, flax, citrus,
lentil, sunflower, and Arabidopsis [11]. Agroinfiltration meth-
ods have also been applied to woody trees including aspen,
poplar, birch, eucalyptus, pines, and spruces [13]. In addition
to leaf tissue, petals of tobacco, petunia, Antirrhinum majus,
Gerbera jamesonii, several species of Dendrobium flowers,
and the fruits of tomatoes and strawberries have also been
successfully agroinfiltrated with transgene constructs [54].
Among these options, lettuce is a prime example to demo-
nstrate the special utility of non-Nicotiana hosts in producing
RPs. Despite the aforementioned advantages of Nicotiana
hosts, they do produce unusually higher levels of phenolics
and alkaloids than other plant species. These compounds
foul purification resins and are difficult to remove from the
target RP in downstream processing, adding to production
resources and costs [55, 56].This is especially problematic for
RPs with pharmaceutical applications, as they need to be free
of these plant compounds to meet regulations of the FDA.
Thus, there is a need to identify plant hosts that produce lower
levels of phenolics and alkaloids yet retain the robustness of
RP production. Lettuce (Lactuca sativa) is already cultivated
commercially in large scales and its yield and speed of
biomass generation can easily match those of Nicotiana
plants. Lettuce produces negligible quantities of phenolics
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and alkaloids and thus would overcome the challenge of
their removal during downstream processing. Agroinfiltra-
tion with nonviral vectors indicated that lettuce expresses a
variety of functional RPs, albeit the expression levels were low
[57, 58]. To further demonstrate the potential of lettuce as a
host for RP production, we explored the use of deconstructed
viral vectors to express pharmaceutical proteins in lettuce
(Table 1). We first examined the expression of a VLP vaccine
candidate for norovirus based on the capsid protein of
Norwalk virus (NVCP) with geminiviral vectors. NVCP was
expressed at levels which are comparable with that in N.
benthamiana, at the highest expression levels ever reported
for a vaccine in lettuce [34]. Furthermore, lettuce-produced
NVCP efficiently assembled intoVLPswith a diameter typical
of native NVCP VLPs [21, 34]. Moreover, these VLPs are
fully functional and can induce potent immune response in
mice [21].These studies demonstrated that lettuce is as robust
as Nicotiana plants for RP production with agroinfiltration.
Beyond that, this study also demonstrated the superiority
of lettuce over Nicotiana plants for expressing VLPs. Owing
to their structural resemblance to native viruses but lacking
infectious viral genomes, VLPs have been shown to have
tremendous potential in immunogenicity, multivalency and
safety as vaccines against many diseases [20]. However, the
porous and dynamic nature of theVLP structure alsomakes it
susceptible to trap contaminant molecules inside. As a result,
it is a very difficult task to remove plant secondary metabo-
lites from the feedstream of Nicotiana plant-produced VLPs
[16]. If not resolved, this problem will diminish the vast
potential of VLPs and plant transient expression technology.
Due to the low level of secondarymetabolites in lettuce tissue,
NVCP VLPs can be purified to high purity from lettuce
extracts without the extra need for elimination of phenolics
and alkaloids [34].
The advantage of lettuce has also been showcased for the
production of MAbs, another group of proteins with high
pharmaceutical relevance. MAbs can be efficiently produced
in several plant hosts. For example, MAbs against Ebola virus
andWNVcanbe expressed at very high levels inN. benthami-
ana with MagnICON and geminiviral vectors [17, 32]. These
plant-produced MAbs are fully functional in protecting ani-
mals from lethal challenge of viral infections [17]. In addition
to the native MAbs, large MAb variants such as tetravalent
antibodies and recombinant immune complexes have been
successfully produced in N. benthamiana [27, 28, 41, 43].
The most popular and efficient method of purifying MAbs
is Protein A affinity chromatography. As a RP itself, Protein
A is costly and can be easily damaged by a cleaning reagent.
Unfortunately, phenolics and alkaloids in N. benthamiana
feedstream foul Protein A resins and are hard to remove
from the target MAb. Consequently, extra purification steps
are required to remove these secondary metabolites from the
feedstream before loading to Protein A resin [17]. Moreover,
frequent cleaning of resins with harsh reagents is necessary to
prevent fouling [59].These extra measures complicate down-
stream processing, shorten the life span of protein A, and
add extra capital and operational cost for MAb production.
Our results indicate that the ammonium sulfate precipitation
step for MAb purification, which is partially responsible for
removing secondarymetabolites from tobacco extract, can be
bypassed due to the negligible amounts of plant compounds
in the lettuce feedstream [18, 34]. Thus, lettuce extracts con-
taining MAbs can be directly loaded onto the Protein A
column, avoiding resin fouling concerns [18, 34]. As a result,
the life cycle of Protein A resin is prolonged and the overall
production cost of MAbs is reduced.
Our success in producing functional VLPs and MAbs
with commercially produced lettuce demonstrated another
advantage of lettuce as a host for large-scale agroinfiltration.
Since agricultural and food industries have already estab-
lished the infrastructure and technology needed for large-
scale lettuce growing and processing, they can be rapidly
adapted for the production of RPs.This suggests that biomass
production could be subcontracted to existing commercial
growers. This will forego the need for capital investment of
purpose-built biomass facilities but allows access to poten-
tially unlimited quantities of inexpensive plant material for
large-scale manufacturing of RPs. Besides lettuce, other plant
species are being explored as hosts for agroinfiltration to
allow for the production of RPs with unique properties.
4. Conclusions
Thedevelopment of deconstructed viral vectors has reinvigo-
rated the field of plant-made RPs and provided a production
platformwith superior protein yield, speed, scalability, versa-
tility, safety, and cost-saving benefits. A recent breakthrough
in plant glycoengineering allows plants to produce RPs with
tailor-made N-glycans and expands the utility of plants in
developing biobetters with superior functional and safety
profiles.The lack of a scalable technology to deliver transgene
into plant cells was one of the remaining hurdles for the com-
mercial application of plant transient systems. As discussed
in this review, this challenge has been overcome effectively by
various agroinfiltration technologies. We believe that further
optimization of agroinfiltration technologies will expedite
the acceptance of plant transient expression systems for the
commercial production of a broad range of RPs.
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